|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Regenicin Inc.
| | | Phone: | (646) 403-3581 | Year Established: | 2007 | Ticker: | RGIN | Exchange: | OTC | Main Contact: | Randall McCoy, CEO | | Other Contacts: | J. Roy Nelson, Ph.D., CSO John Weber, Interim CFO
| | Company Description | Regenicin, formerly known as Windstar, is an early-stage, biotechnology company specializing in the development of regenerative cell therapies for wound care and tissue regeneration. Regenicin's lead product is, NovaDerm® a cultured cell technology that uses a small full thickness biopsy of the patient's skin that can be grown in the laboratory to generate new living skin for grafting large areas of the patient in cases where there is insufficient healthy skin to cover the damaged areas (wounds, ulcers or thermal electrical or chemical burns). | |
|
|
|
|
|